Prognostic factors in patients with metastatic renal cell carcinoma

Acta Urologica Japonica

Volumn 56, Issue 2, 2010, Pages 75-79

  Inoue, Ryuta ^a   Takahashi, Atsushi ^a   Takasugi, Shogo ^a   Masumori, Naoya ^a   Tsukamoto, Taiji ^a   Hasegawa, Tadashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Metastasis; Prognostic factors; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFICATION; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 77949860373     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Motzer RJ, Mazumdar M, Bacik J, et al. : Survival and prognostic strafication of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17: 2530-2540, 1999
2. Naito S, Yamamoto N, Takayama T, et al. : Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era : a cooperative group report of 1463 patients. Eur Urol, published online ahead of print on January 3, 2009
3. de Forges A, Rey A, Klink M, et al. : Prognostic factord of adult metastatic renal cell carcinoma : a multivariate analysis. Semin Surg Oncol 4 : 149-154, 1988
4. Miyao N, Oda T, Shigyou M, et al. : Pre-operatively determined prognostic factors in metastatic renal cell carcinoma. Eur Urol 31: 292-296, 1997
5. Atzpodien J, Royston P, Wandert T, et al. : Metastatic renal carcinoma comprehensive prognostic system. BrJ Cancer 88: 348-353, 2003
6. Bukowski RM, Negrier S and Ebon P: Prognostic factors in patients with advanced renal cell carcinoma : development of an international kidney cancer working group. Clin Cancer Res 10 : 6310S-6314S, 2004
7. Negrier S, Escudier B, Gomez F, et al. : Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated cytokines. Ann Oncol 13 : 1460-1468, 2002
8. Leibovich B, Cheville JC, Lohse CM, et al. : A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma : a stratification tool for prospective clinical trials. J Urol 174: 17591763, 2005
9. Lopez Hanninen E, Kirchner H and Atzpodien J : Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Urol 155 : 19-25, 1996
10. Argiris A and Murren JR : Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 7: 437-447, 2001
11. ) Brizel DM, Schroeder T, Scher RL, et al. : Elevated tumor lactate concentrations predict for an increased risk of metastasis in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353, 2001
12. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. : Lactate dehydrogenase 5 expression in operable colorectal cancer : association with survival and activated vascular endothelial growth factor pathway-a report of the tumor angiogenesis research group. J Clin Oncol 24: 4301-4308, 2006
13. Kolev Y, Uetake H, Takagi Y, et al.: Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1 alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 15: 23362344, 2008
14. Escudier B, Eisen T, Stadler WM, et al. : Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125-134, 2007
15. Motzer RJ, Hutson, TE, Tomczak P, et al. : Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124, 2007
16. Ito N, Eto M, Nakamura E, et al.: STAT3 polymorphism predicts interferon-alpha response in patients with mestatic renal cell carcinoma. J Clin Oncol 25: 2785-2791, 2007